Latest news with #DallahHealthcare
Argaam
27-05-2025
- Business
- Argaam
Dallah plans 622,450 share buyback for employee incentive program
Dallah Healthcare Co.'s (Dallah Health) board of directors recommended the buyback of a maximum of 622,450 shares, to be allocated for the employee stock incentive program (ESIP), according to a statement to Tadawul today, May 27. The repurchase will be financed through Dallah's own resources, as it holds 0.37% of treasury shares. Dallah added that it will seek approval for the buyback process during the next extraordinary general meeting (EGM), as required by Paragraph 4 of Article 17 of the Executive Regulations of the Companies Law for Listed Joint Stock Companies. Additionally, the company affirmed that it will comply with the solvency requirements outlined in Paragraph 3 of Article 17 of the same regulations. Dallah also noted that the repurchased shares will not have voting rights in the shareholders' assemblies. The company currently holds 377,550 shares as treasury shares, which were originally repurchased to be retained as treasury shares. It aims to potentially utilize them in future swap transactions for acquiring shares or stakes in a company or for purchasing an asset. The board of directors recommended changing the purpose of these shares to be allocated to the ESIP. This change will be presented to the EGM for approval. As a result, the total number of shares allocated to the ESIP will reach one million shares, assuming the company proceeds with purchasing the maximum number of shares mentioned in the announcement above, in addition to changing the purpose of the 377,550 shares shares currently held as treasury shares.
Zawya
16-05-2025
- Business
- Zawya
Saudi: Dallah Healthcare's net profits grow 30% in Q1-25
Riyadh - Dallah Healthcare Company reported 30.39% higher net profits at SAR 155.56 million in the first quarter (Q1) of 2025, compared to SAR 119.30 million in Q1-24. The earnings per share (EPS) stood at SAR 1.59 as of 31 March 2025, marking a 30% hike from SAR 1.22 in Q1-24, as per the financial results. Furthermore, the revenues rose by 6.20% year-on-year (YoY) to SAR 832.75 million in the first three months (3M) of 2025 from SAR 784.06 million. Quarter-on-quarter (QoQ), the net profits in Q1-25 soared by 36.57% from SAR 113.90 million in Q4-24, while the revenues increased by 2.96% from SAR 808.76 million. At the end of December 2024, Dallah Healthcare generated an annual rise in net profits to SAR 471.20 million from SAR 360.12 million. All Rights Reserved - Mubasher Info © 2005 - 2022 Provided by SyndiGate Media Inc. (
Asharq Al-Awsat
09-04-2025
- Business
- Asharq Al-Awsat
Saudi Healthcare Sector Posts $1.3 Billion in Profits for 2024 Amid Strong Growth
Saudi Arabia's listed healthcare companies delivered robust financial performance in 2024, reporting a combined net profit of SAR4.86 billion ($1.3 billion), according to data from the Saudi Stock Exchange (Tadawul). The figure marks a 13.65% increase from SAR3.95 billion ($1.1 billion) in 2023, driven by higher revenues, operational transformation, and improved efficiencies across the sector. Total revenues for the year also rose significantly, reaching SAR33.87 billion ($9 billion), up 16.7% from SAR29.02 billion ($7.7 billion) the previous year. Industry analysts attribute this growth to a surge in outpatient visits, pharmacy sales, and a continued push for digital transformation. The sector comprises 11 publicly listed companies, including Dr. Sulaiman Al Habib Medical Group, Mouwasat Medical Services, Dallah Healthcare, Al Hammadi, Care, Saudi Chemical Company (AJA Pharma), Saudi German Health, Fakeeh Care, Al Moosa Health, Dar Al Dawa, and Ayyan Investment. According to data from the Ministry of Investment, the private sector currently provides 24% of healthcare services in the Kingdom, while government institutions account for 60%. The remaining 16% is covered by other public entities. As part of Vision 2030, Saudi Arabia has launched wide-ranging reforms aimed at increasing private sector involvement and shifting healthcare financing toward an insurance-based model. The Ministry of Health is transitioning from its traditional role as a healthcare provider to that of the sole regulator. The National Transformation Program aims to raise the private sector's contribution to total healthcare spending from 25% to 35%. These reforms have created fertile ground for new investment, with more than SAR50 billion ($13.3 billion) in healthcare commitments announced during the Global Health Exhibition in Riyadh last October. Top Performers in 2024 Sulaiman Al Habib Medical Group led the sector with SAR2.31 billion in net profit—accounting for 47.6% of total industry earnings. The group's profits rose 13.16% year-on-year, supported by a 17.8% increase in revenue, which reached SAR11.2 billion in 2024. The company attributed the growth to higher patient volumes in its hospital network and a corresponding rise in pharmacy sales. Mouwasat Medical Services ranked second, reporting SAR645.76 million in profits. Despite a slight 1.81% decline from 2023, the company grew its revenue by 6.4% to SAR2.87 billion. Mouwasat cited an increase in outpatient visits and higher occupancy rates in inpatient wards as key drivers, alongside improved operational efficiency. Dallah Healthcare secured third place with SAR471.2 million in profit, reflecting a strong 30.84% year-on-year increase. Revenues rose 8.93% to SAR3.2 billion. The company attributed its success to improved gross margins, increased efficiency, and better performance from affiliated firms. Other notable performances included Saudi German Health, which reported a staggering 1,555% surge in profits, and Saudi Chemical Company's healthcare division (AJA Pharma), which posted a 59.21% increase in earnings. Analysts: A Standout Year for the Sector Commenting on the sector's performance, Dr. Sulaiman Al-Humaid Al-Khaldi, a financial analyst and member of the Saudi Economic Association, described 2024 as an exceptional year for Saudi healthcare. 'The results reflect the success of strategic health reforms under Vision 2030,' he said, noting government support, rising demand, and digital transformation as key contributors. He highlighted several growth factors, including increased public health spending, the rollout of digital health and preventive care initiatives, rising life expectancy, and growing public awareness of health services. 'Demand for comprehensive and specialized care is increasing, and the sector is rising to meet it,' Al-Khaldi said. He also emphasized the government's commitment to digital healthcare, pointing to investments in telemedicine, unified health records, and artificial intelligence in diagnostics and treatment. Outlook and Challenges Mohammed Hamdi Omar, CEO of consulting firm G-World, expects the sector's momentum to continue. He forecasts profit growth between 12% and 14% in Q2 and Q3 of 2025, rising to 14%–16% by Q4 2025 and early 2026. He pointed to ongoing privatization efforts, increased insurance coverage, and further investment in digital health tools as primary drivers. 'The sector is benefiting from operational efficiency and an expansion of specialized services,' Omar said. He added that government support—estimated at SAR51.75 billion ($13.8 billion)—has improved the investment environment and extended insurance coverage. However, both analysts cautioned about potential risks, including shortages in qualified medical professionals, rising costs, and regulatory changes. They emphasized the importance of aligning with Vision 2030 by investing in innovation, digital transformation, and specialized services. 'Healthcare is no longer just a public service,' Omar said. 'It's becoming a strategic pillar of Saudi Arabia's economic development and a gateway for medical tourism and global competitiveness.'
Argaam
07-04-2025
- Business
- Argaam
Dallah expects revenue to grow by SAR500M in first year after Al-Salam-Al-Ahsa acquisition in Eastern Province
Dallah Healthcare Co. (Dallah Health), which is listed on Tadawul under the ticker symbol: 4004 and ISIN: SA135G51UI10, and one of the leading specialized healthcare service providers in Saudi Arabia, announced today, April 7, closing its acquisition of AYYAN Investment Company's shares in Al-Ahsa Medical Services Co. and Al-Salam Medical Services Co. in the Eastern Province. This move aligns with the company's strategy that aims to expand its geographical footprint and enhance its contribution to the development of the Kingdom's healthcare sector. The acquisition reflects Dallah's commitment to delivering the highest value to shareholders in the long term, in line with its effort to enhance its leadership in the healthcare industry and provide advanced medical services that meet the needs of the Saudi society according to the highest quality standards. On this occasion, Eng. Tarek Othman Alkasabi, Chairman of Dallah Healthcare, said: 'Dallah Healthcare proceeds confidently with its growth strategy to strengthen its position as the most reliable provider of healthcare services in Saudi Arabia. The new acquisition aims to facilitate access to our medical services which are distinguished by expertise, quality, and professionalism—for a larger segment of the society. It will also support the company's development ambitions by increasing revenue and integrating the knowhow and resources of acquired companies to enhance the quality and efficiency of the services we offer to our patients.' Under the deal, Dallah acquired a 97.41% stake in Al-Ahsa Medical Services Co. (Al-Ahsa Hospital) which is valued at SAR 409 million, and 100% of Al-Salam Medical Services Co. (Al-Salam Hospital) which is valued at SAR 251 million. In exchange, Dallah issued 3.89 million new shares to AYYAN Investment Company, representing 3.83% of Dallah's capital. The acquisition contributed to increasing the group's capacity by 37% starting mid-March 2025, adding 424 beds (274 at Al-Ahsa Hospital and 150 at Al-Salam Hospital). Once fully operates, Al-Salam Hospital's capacity will jump 65% to 475 beds, bringing the group's total capacity to 1,903 beds. It will reach 2,560 beds with the addition of associates*. This reflects significant growth opportunities and broad prospects for the group to enhance its presence and market share. The deal is expected to increase the group's revenues by approximately SAR 500 million in 2025. The revenues will see a further rise in subsequent years, driven by growth in occupancy rates of both hospitals - particularly Al-Salam Hospital. Dallah's long-standing expertise in the healthcare sector will lead to a qualitative improvement in the medical services provided at both hospitals, thereby increasing revenues. *Associates account for 657 beds. For more details, please refer to the Investor Relations page on Dallah Healthcare's website, as well as the Issuer Announcements page on the Saudi Exchange (Tadawul) website.
Argaam
23-03-2025
- Business
- Argaam
Edaa implements capital hike on Dallah Healthcare stock
The Securities Depository Center Co. (Edaa) applied today, March 23, the increase in the number of Dallah Healthcare Co. 's shares, resulting from its recent capital top-up, to the accounts of eligible shareholders, according to a Tadawul statement. Dallah Healthcare's extraordinary general meeting (EGM) had recently approved the board's proposal to raise the company's capital from SAR 976.81 million to SAR 1.02 billion, through issuing 3.89 million ordinary shares, according to data available with Argaam. The capital top-up is aimed at financing Dallah Healthcare's acquisition of 97.41% of Al-Ahsa Medical Services Co. and 100% of Al-Salam Medical Services Co., both owned by AYYAN Investment Co. The table below details Dallah Healthcare's capital structure: With 14.61 million shares to be purchased in Al-Ahsa Medical Services, the swap ratio is about 0.16 new Dallah Healthcare shares per one Al-Ahsa share. While with 20 million Al-Salam Medical Services shares to be acquired, the swap ratio is about 0.07 new Dallah Healthcare shares per one Al-Salam share. The post-acquisition ownership of shareholders to whom new ordinary shares will be issued in Dallah Healthcare under the capital top-up amounted to 3.83%.
